New Covid-19 vaccine demonstrates ‘89% efficacy’

An experimental Covid-19 vaccine appears to offer strong protection in late-stage UK and South Africa studies, said manufacturer Novavax. The UK has secured access to 60 million doses of the vaccine, called NVX-CoV2373.

Popular Videos

Watch MoreMore Videos

Headlines

More Videos

Download the Sunday World app

Now download the free app for all the latest Sunday World News, Crime, Irish Showbiz and Sport. Available on Apple and Android devices

Latest News